VC assets accounted for 19% of Yale’s endowment portfolio by June 2018 compared with 13.7% four years previously, as resources shifted away from leveraged buyouts and real estate.

Garwood Medical Devices is developing two therapeutic electrode-powered products based on licences from University of Buffalo, having last raised $3.6m in 2016.

Credit Suisse-backed SPF Investment Management has contributed to a $75m series B round for Pagantis, the online lender previously known as Digital Origin.

The Fosun-backed wedding services marketplace will use the proceeds from the series D-1 round to further develop its AI and big data technologies.

Founding investor Lundbeckfonden Emerge returned to co-lead a series A round for the gene editing drug developer with Life Science Partners.

Medical device producer Oscor has led the heart disease treatment system developer's $20m series D round in connection with a strategic partnership.

Natiowide has taken a minority stake in financial services portal developer 10x Future Technologies through a $16.9m series B investment.

The Cambridge spinout plans to build out the business for its automated customer support platform after collecting $12m in series A funding.

Gyroscope Therapeutics recently commenced phase 1/2 clinical trials on a retinal gene therapy for dry age-related macular degeneration.

The seed capital will help UAB-founded TriAltus Bioscience commercialise its protein purification materials, which are already being used by research clients in the US, Brazil and EU.